# Tao Synergies Inc. Common Stock (TAOX)

> Tao Synergies Inc. Common Stock (TAOX) trades at $1.73 (-7.49%) as of 7:30:02 PM EST on Nov 18, 2026, -48.82% over the past month. Market cap is $15.04M, with 3.7 days to cover in short interest.

Canonical: https://massive.com/quote/taox
Data as of: 2026-11-19T00:30:02.645Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$1.73** -0.14 (-7.49%)
As of 7:30:02 PM EST on Nov 18, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Tao Synergies Inc. Common Stock (TAOX) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -7.49% |
| 1W | -31.89% |
| 1M | -48.82% |
| YTD | -52.99% |
| 1Y | -73.38% |
| 52-wk range | $1.70 – $7.85 |

From daily closes through Nov 18, 2026.

## Key statistics

Today's trading snapshot for TAOX: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $1.73 – $1.95 |
| Open | $1.92 |
| Prev close | $1.87 |
| Volume | 107.17K |
| Market cap | $15.04M |
| Shares out | 8.04M |

## Valuation and profitability ratios

Valuation and profitability ratios for Tao Synergies Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 18.46 |
| P/B | 0.79 |
| P/FCF | — |
| ROE | -79.7% |
| ROA | -53.7% |
| Debt/Equity | 0.00 |
| Div yield | 6.85% |

As of Nov 17, 2026

## Insider trading

[Tao Synergies Inc. Common Stock (TAOX) insider trading](https://massive.com/quote/taox/insider-trading.md): open-market Form 4 buys and sells by Tao Synergies Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Tao Synergies Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Oct 14, 2025 · Private placement
  “TAO Synergies Inc. (the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain accredited investors (the "Investors"), pursuant to which it agreed to sell to the Investors in a private placement (the "Private Placement") (i) an aggregate of 11,000 shares of the Company's newly designated Series E convertible preferred stock, par value $0.001, with a stated value of $1,000 per share (the "Preferred Stock"), initially convertible into up to 1,375,000 shares of the Company's common stock at an initial conversion price of $8.00 and (ii) warrants to purchase up to an aggregate of 1,375,000 shares of Common Stock.”
- Aug 29, 2025 · Director appointment
  “In connection with the aforementioned resignations, on August 29, 2025, the Company appointed Robert Ephron to the Board. Mr. Ephron joins the Company from JK Polk Holdings where he has served as an advisor in advertising and sales since 2024. Mr. Ephron was previously vice president of advertising and sales at Paramount from 2017 to 2023 and vice president of advertising and sales at Viacom from 2015 to 2017. Mr. Ephron will serve on the audit, compensation and nominating and corporate governance committees of the Board.”
- Aug 6, 2025 · Capital allocation update
  “TAO Synergies Inc. (the "Company") issued a press release announcing its acquisition of TAO tokens as part of its digital asset treasury strategy directed toward TAO... the Company announced aggregate purchases to date of 42,111 TAO tokens.”
- Jul 17, 2025 · Capital allocation update
  “On July 17, 2025, the Company announced aggregate purchases to date of 29,899 TAO tokens totaling approximately $10 million. TAO Synergies Inc. (the "Company") issued a press release announcing its acquisition of TAO tokens as part of its digital asset treasury strategy directed toward TAO.”

## TAOX short interest

How heavily TAOX is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 3.7 |
| Short interest | 414.44K |
| Avg volume | 111.43K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## About Tao Synergies Inc. Common Stock

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | FINANCE SERVICES |
| Employees | 4 |
| Listed | Dec 7, 2020 |

[Company website](https://www.taosynergies.com)

## FAQ

### What is the Tao Synergies Inc. Common Stock (TAOX) stock price today?

Tao Synergies Inc. Common Stock (TAOX) is trading at $1.73 (-7.49% on the day) as of 7:30:02 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Tao Synergies Inc. Common Stock?

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X…

### What is the short interest in TAOX?

As of Oct 30, 2026, TAOX has 414.44K shares short and 3.7 days to cover.

### What exchange is TAOX listed on?

Tao Synergies Inc. Common Stock (TAOX) trades on Nasdaq in USD, in the FINANCE SERVICES industry.

## Live data

Prices here are 15-minute delayed. For real-time TAOX quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=TAOX`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Tao Synergies Inc. Common Stock (TAOX) insider trading](https://massive.com/quote/taox/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
